Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Gastritis II: Pathophysiology

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.

Peptic Ulcer

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Update on the Management of Helicobacter pylori Infection in Children and Adolescents.

Current gastroenterology reports·2025

Same author

Optimizing proton-pump inhibitor therapy in paediatric eosinophilic esophagitis through <i>CYP2C19</i> pharmacogenetic testing.

Journal of the Canadian Association of Gastroenterology·2025

Same author

Survival of intracellular pathogens in response to mTORC1- or TRPML1-TFEB-induced xenophagy.

Autophagy reports·2025

Same author

The Hardy Side of Helicobacter pylori: Uncovering Ancient Adaptations and Host Interactions.

Gastroenterology·2024

Same author

Reevaluating Stemness in the Intestinal Crypt.

Gastroenterology·2024

Same author

Lysosomes drive the piecemeal removal of mitochondrial inner membrane.

Nature·2024

Search research articles

Related Experiment Video

Updated: May 26, 2026

High Resolution Electron Microscopy of the Helicobacter pylori Cag Type IV Secretion System Pili Produced in Varying Conditions of Iron Availability

High Resolution Electron Microscopy of the Helicobacter pylori Cag Type IV Secretion System Pili Produced in Varying Conditions of Iron Availability

Published on: November 21, 2014

Recent advances in Helicobacter pylori pathogenesis.

Michal Sibony¹, Nicola L Jones

¹Division of Gastroenterology, Hepatology and Nutrition, Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada.

Current Opinion in Gastroenterology

|December 14, 2011

Summary

Helicobacter pylori (H. pylori) infection is linked to gastric diseases, with new research revealing its role in cancer via CagA pathways and the influence of the human microbiome. Understanding these H. pylori interactions is crucial for future treatments.

More Related Videos

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance

Published on: March 7, 2025

Related Experiment Videos

Last Updated: May 26, 2026

High Resolution Electron Microscopy of the Helicobacter pylori Cag Type IV Secretion System Pili Produced in Varying Conditions of Iron Availability

High Resolution Electron Microscopy of the Helicobacter pylori Cag Type IV Secretion System Pili Produced in Varying Conditions of Iron Availability

Published on: November 21, 2014

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance

Published on: March 7, 2025

Area of Science:

Gastroenterology
Microbiology
Immunology

Background:

Helicobacter pylori (H. pylori) is a significant factor in gastric pathologies.
The prevalence of H. pylori infection is decreasing in developed nations.
Understanding H. pylori-host interactions is vital due to changing infection epidemiology.

Purpose of the Study:

To review recent discoveries in H. pylori disease pathogenesis.
To explore novel mechanisms of H. pylori-induced diseases.
To examine the impact of evolving H. pylori epidemiology on disease.

Main Methods:

Systematic review of the latest research on H. pylori pathogenesis.
Analysis of studies on H. pylori cytotoxin-associated gene (CagA) and carcinogenesis.
Investigation of the role of the human microbiome in H. pylori-related diseases.

Main Results:

Novel pathways in CagA-mediated carcinogenesis identified, involving proliferation and apoptosis dysregulation.
The human microbiome's critical role in H. pylori disease development highlighted.
Mechanisms underlying the inverse correlation between H. pylori and asthma/inflammatory bowel disease are being elucidated.

Conclusions:

Recent findings offer new targets for understanding H. pylori disease mechanisms.
Further research into potential therapeutic strategies is warranted.
The beneficial roles of H. pylori and the impact of bacterial flora on disease require further investigation for improved patient care.